Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1998 May;152(5):1125–1127.

The pathogenesis of amyloidosis: understanding general principles.

P Westermark 1
PMCID: PMC1858576  PMID: 9588878

Full text

PDF
1125

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aleshkov S., Abraham C. R., Zannis V. I. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease. Biochemistry. 1997 Aug 26;36(34):10571–10580. doi: 10.1021/bi9626362. [DOI] [PubMed] [Google Scholar]
  2. Axelrad M. A., Kisilevsky R., Willmer J., Chen S. J., Skinner M. Further characterization of amyloid-enhancing factor. Lab Invest. 1982 Aug;47(2):139–146. [PubMed] [Google Scholar]
  3. Benditt E. P., Eriksen N. Chemical classes of amyloid substance. Am J Pathol. 1971 Oct;65(1):231–252. [PMC free article] [PubMed] [Google Scholar]
  4. Benditt E. P., Eriksen N., Hermodson M. A., Ericsson L. H. The major proteins of human and monkey amyloid substance: Common properties including unusual N-terminal amino acid sequences. FEBS Lett. 1971 Dec 1;19(2):169–173. doi: 10.1016/0014-5793(71)80506-9. [DOI] [PubMed] [Google Scholar]
  5. Botto M., Hawkins P. N., Bickerstaff M. C., Herbert J., Bygrave A. E., McBride A., Hutchinson W. L., Tennent G. A., Walport M. J., Pepys M. B. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nat Med. 1997 Aug;3(8):855–859. doi: 10.1038/nm0897-855. [DOI] [PubMed] [Google Scholar]
  6. COHEN A. S., CALKINS E. Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature. 1959 Apr 25;183(4669):1202–1203. doi: 10.1038/1831202a0. [DOI] [PubMed] [Google Scholar]
  7. Castano E. M., Prelli F., Wisniewski T., Golabek A., Kumar R. A., Soto C., Frangione B. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. Biochem J. 1995 Mar 1;306(Pt 2):599–604. doi: 10.1042/bj3060599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Castaño E. M., Prelli F., Pras M., Frangione B. Apolipoprotein E carboxyl-terminal fragments are complexed to amyloids A and L. Implications for amyloidogenesis and Alzheimer's disease. J Biol Chem. 1995 Jul 21;270(29):17610–17615. doi: 10.1074/jbc.270.29.17610. [DOI] [PubMed] [Google Scholar]
  9. Chargé S. B., Esiri M. M., Bethune C. A., Hansen B. C., Clark A. Apolipoprotein E is associated with islet amyloid and other amyloidoses: implications for Alzheimer's disease. J Pathol. 1996 Aug;179(4):443–447. doi: 10.1002/(SICI)1096-9896(199608)179:4<443::AID-PATH612>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
  10. Colon W., Kelly J. W. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry. 1992 Sep 15;31(36):8654–8660. doi: 10.1021/bi00151a036. [DOI] [PubMed] [Google Scholar]
  11. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993 Aug 13;261(5123):921–923. doi: 10.1126/science.8346443. [DOI] [PubMed] [Google Scholar]
  12. Elliott-Bryant R., Cathcart E. S. Apolipoprotein E and apolipoprotein A-1 knock-out mice readily develop amyloid A protein amyloidosis. Clin Immunol Immunopathol. 1997 Oct;85(1):104–108. doi: 10.1006/clin.1997.4397. [DOI] [PubMed] [Google Scholar]
  13. Glenner G. G., Eanes E. D., Bladen H. A., Linke R. P., Termine J. D. Beta-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem. 1974 Dec;22(12):1141–1158. doi: 10.1177/22.12.1141. [DOI] [PubMed] [Google Scholar]
  14. Glenner G. G., Terry W., Harada M., Isersky C., Page D. Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses. Science. 1971 Jun 11;172(3988):1150–1151. doi: 10.1126/science.172.3988.1150. [DOI] [PubMed] [Google Scholar]
  15. Glenner G. G., Wong C. W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984 May 16;120(3):885–890. doi: 10.1016/s0006-291x(84)80190-4. [DOI] [PubMed] [Google Scholar]
  16. Harr S. D., Uint L., Hollister R., Hyman B. T., Mendez A. J. Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease. J Neurochem. 1996 Jun;66(6):2429–2435. doi: 10.1046/j.1471-4159.1996.66062429.x. [DOI] [PubMed] [Google Scholar]
  17. Hoshii Y., Kawano H., Cui D., Takeda T., Gondo T., Takahashi M., Kogishi K., Higuchi K., Ishihara T. Amyloid A protein amyloidosis induced in apolipoprotein-E-deficient mice. Am J Pathol. 1997 Oct;151(4):911–917. [PMC free article] [PubMed] [Google Scholar]
  18. Johan K., Westermark G., Engström U., Gustavsson A., Hultman P., Westermark P. Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2558–2563. doi: 10.1073/pnas.95.5.2558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jordán J., Galindo M. F., Miller R. J., Reardon C. A., Getz G. S., LaDu M. J. Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J Neurosci. 1998 Jan 1;18(1):195–204. doi: 10.1523/JNEUROSCI.18-01-00195.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kaneko K., Zulianello L., Scott M., Cooper C. M., Wallace A. C., James T. L., Cohen F. E., Prusiner S. B. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10069–10074. doi: 10.1073/pnas.94.19.10069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kindy M. S., King A. R., Perry G., de Beer M. C., de Beer F. C. Association of apolipoprotein E with murine amyloid A protein amyloid. Lab Invest. 1995 Oct;73(4):469–475. [PubMed] [Google Scholar]
  22. Kindy M. S., Rader D. J. Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient mice. Am J Pathol. 1998 May;152(5):1387–1395. [PMC free article] [PubMed] [Google Scholar]
  23. Lindhorst E., Young D., Bagshaw W., Hyland M., Kisilevsky R. Acute inflammation, acute phase serum amyloid A and cholesterol metabolism in the mouse. Biochim Biophys Acta. 1997 Apr 25;1339(1):143–154. doi: 10.1016/s0167-4838(96)00227-0. [DOI] [PubMed] [Google Scholar]
  24. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4245–4249. doi: 10.1073/pnas.82.12.4245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Näslund J., Thyberg J., Tjernberg L. O., Wernstedt C., Karlström A. R., Bogdanovic N., Gandy S. E., Lannfelt L., Terenius L., Nordstedt C. Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain. Neuron. 1995 Jul;15(1):219–228. doi: 10.1016/0896-6273(95)90079-9. [DOI] [PubMed] [Google Scholar]
  26. Premkumar D. R., Cohen D. L., Hedera P., Friedland R. P., Kalaria R. N. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol. 1996 Jun;148(6):2083–2095. [PMC free article] [PubMed] [Google Scholar]
  27. Richey P. L., Siedlak S. L., Smith M. A., Perry G. Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis. Biochem Biophys Res Commun. 1995 Mar 17;208(2):657–663. doi: 10.1006/bbrc.1995.1389. [DOI] [PubMed] [Google Scholar]
  28. Rocken Christoph, Paris Diana, Steusloff Karen, Saeger Wolfgang. Investigation of the Presence of Apotipoprotein E, G lycosaminoglycans, Basement Membrane Proteins, and Protease inhibitors in Senile interstitial Amyloid of the Pituitary. Endocr Pathol. 1997 Autumn;8(3):205–214. doi: 10.1007/BF02738787. [DOI] [PubMed] [Google Scholar]
  29. Snow A. D., Bramson R., Mar H., Wight T. N., Kisilevsky R. A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis. J Histochem Cytochem. 1991 Oct;39(10):1321–1330. doi: 10.1177/39.10.1940305. [DOI] [PubMed] [Google Scholar]
  30. Soto C., Castaño E. M., Prelli F., Kumar R. A., Baumann M. Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, gelsolin and AA amyloids. FEBS Lett. 1995 Sep 4;371(2):110–114. doi: 10.1016/0014-5793(95)00863-5. [DOI] [PubMed] [Google Scholar]
  31. Strittmatter W. J., Weisgraber K. H., Huang D. Y., Dong L. M., Salvesen G. S., Pericak-Vance M., Schmechel D., Saunders A. M., Goldgaber D., Roses A. D. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8098–8102. doi: 10.1073/pnas.90.17.8098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Verchere C. B., D'Alessio D. A., Palmiter R. D., Weir G. C., Bonner-Weir S., Baskin D. G., Kahn S. E. Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3492–3496. doi: 10.1073/pnas.93.8.3492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wetzel R. Mutations and off-pathway aggregation of proteins. Trends Biotechnol. 1994 May;12(5):193–198. doi: 10.1016/0167-7799(94)90082-5. [DOI] [PubMed] [Google Scholar]
  34. Wisniewski T., Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett. 1992 Feb 3;135(2):235–238. doi: 10.1016/0304-3940(92)90444-c. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES